


















Femoral Access 3.4 48 22 49 79 24 48 69
Brachial Access 24 40 14 78 88 16 40 68
P Value .008 .03 .5 .1 .2 .37 .63 .8
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Changes in Kidney Volume After Renal Artery Stent-
ing: Does Stenting Preserve Renal Mass?
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Objectives: Renal artery stenting (RAS) improves blood
pressure (BP) control and renal function in some patients, but
others derive no clear benefit. Proponents of RAS contend
that RAS will preserve renal mass even if there is no improve-
ment in BP or renal function. Currently there are limited data
to support that notion. The purpose of this study was to assess
the longitudinal changes in renal volume after RAS.
Methods: The study cohort consisted of 35 patients
with longitudinal imaging available for renal volume quan-
tification. Renal volume was estimated as kidney length 
width depth/2 based on preoperative CTA orMRA. For
each patient, the clinical response of BP and renal function
to RAS was categorized according to modified AHA guide-
lines. Changes in renal volume were assessed using paired
nonparametric analyses.
Results: The median age of the cohort was 60 years
(interquartile range [IQR], 60-74 years). A favorable BP
response was observed in 10 of 35 patients (29%). At a
median interval between imaging studies of 18 months
(IQR, 10-31 months), ipsilateral renal volume was signifi-
cantly increased from baseline (147 vs. 135 cm3; P
0.025). This represents a 4% relative increase in ipsilateral
kidney volume from baseline. A significant negative corre-
lation between preoperative renal volume and the relative
change in renal volume postoperatively (r  0.42;
P0.0055) suggests that smaller kidneys experienced the
greatest gains in renal volume after stenting. It is notewor-
thy that the 25 patients with no change in BP or renal
function—clinical failures using traditional definitions—
experienced a 12% relative increase in ipsilateral renal vol-
ume after RAS.
Conclusions: These data lend credence to the belief
that RAS preserves renal mass. This benefit of RAS even
extends to those patients who would be considered treat-
ment failures by traditional definitions. It remains unknown
whether the changes in renal mass induced by RAS will
translate into more stable renal function over the
long-term.
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Door To Treatment Time - Identifying Opportunities
for Process Improvement: Results from an Institution
Based Protocol Caring for Patients with Ruptured
Aortic Aneurysms
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Objectives: Time is of essence while caring for patients
with ruptured aortic aneurysms (RAAA). Multiple factors
which are beyond the control of treating physician play a
role in provision of timely care to these critically ill patients.
We examined time line of various events and its impact on
the process improvement since the inception of a protocol
for patients with ruptured aortic aneurysms.
Methods: A protocol was instituted in August 2009
which included a dedicated team with easy accessibility to
referring hospitals to streamline the care pathway for pa-
tients with RAAA. A prospective data base was established
to record the door to treatment time for patients. Besides
patient demographics, mode of transfer, various timelines
including time spent at the referring facility to diagnosis,
transfer time, wait time at the receiving hospital and overall
time were analyzed. A comparative analysis using two
–sample Wilcoxon test was then made between patients
who were treated prior to group 1 (January 2008-August
2009) and after group 2 (August 2009-November 2010)
implementation of protocol.
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Results: In group 1 there were 26 patients while
group 2 included 36 patients accounting for a 55%
increase in patients treated with RAAA. There was no
difference in the age, mode of transfer. While all the
patients in group 1 were treated with open procedures,
36% patients in group 2 were treated with endovascular
repair. Table 1 shows the results of comparative analysis
of various timelines. There was a statistical difference
with reduction in the overall door –treatment time after
the implementation of the protocol.
Conclusions: While various therapeutic interven-
tions have improved the outcome for patients with rup-
tured aortic aneurysms, provision of timely care is equally
important. The observations from our study identify the
need for dedicated protocols which enable early recog-
nition by increasing awareness, effective communication,
and rapid transfer to centers caring for patients with
ruptured aneurysms. The study also suggests the need to
have a common protocol for process improvement at the
national level and creation of centers treating ruptured
aortic aneurysms.
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The Impact of Adjunctive Iliac Stenting on Femoral-
Femoral Bypass in Contemporary Practice
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Objectives: Most reports of femoral-femoral bypass
(FFB) were published before the era of endovascular inter-
vention. This study examines the utilization and impact of
adjunctive endovascular intervention on FFB in contempo-
rary practice.
Methods: We reviewed 253 FFB performed in 247
patients between 1984 and 2010. Primary endpoints
including graft patency, primary assisted patency, limb
salvage and survival were assessed using Kaplan-Meier
life table analysis. Univariate and multivariate analyses
were performed to determine predictors of primary
endpoints.
Results: The indication for FFB included claudica-
tion(27% n69) and critical limb ischemia(72% n184).
Forty-eight patients were treated urgently for acute isch-
emia. Mean follow-up was 5.6(5.5) years. Over the
study interval, adjunctive iliac stent placement increased
significantly from 0% to 54% (p-trend0.001) while the
rate of axillo-femoral bypass or no inflow procedure
decreased from 100% to 46% (p-trend0.001). Despite
increased utilization, iliac stenting was associated with
both decreased five year primary graft patency, and pri-
mary assisted patency, although did not impact limb
salvage or overall survival. (Table) Five year primary
patency among claudicants and CLI patients was 65%
and 68% respectively.
Conclusions: The incidence of iliac stent placement in
conjunction with FFB has increased significantly over time
in contemporary practice. Reliance on iliac stents for FFB
inflow is paradoxically associated with both diminished
primary and primary assisted graft patency when compared
to historical controls. These findings highlight the impor-








Salvage P Survival P
Non-
Stented 71% 87% 91% 45%
Ax-fem 74% 0.004 85% 0.002 91% 0.521 40% 0.568
Stent 44% 61% 87% 44%
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